Coherus BioSciences to Present at Leerink Healthcare Conference on February 11
February 04 2015 - 4:00PM
Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical
biologics platform company focused on the global biosimilar market,
today announced that it will participate in a fireside chat at the
2015 Leerink Global Healthcare Conference on Wednesday, February 11
at 1:50 pm ET in New York City.
A live and archived webcast of the presentation will be
available on the Investor Relations page of the Coherus website at
http://investors.coherus.com.
About Coherus BioSciences, Inc.
Coherus is a late-stage clinical biologics platform company
focused on the global biosimilar market. Headquartered in the San
Francisco Bay Area and composed of a team of industry veterans with
decades of experience in pioneering biologics companies, our goal
is to become a global leader in the biosimilar market by leveraging
our team's collective expertise in key areas such as process
science, analytical characterization, protein production and
clinical-regulatory development. Coherus' commercialization
partnerships include global pharmaceutical companies in Europe,
Asia and Latin America.
Biosimilars are intended for use in place of existing, branded
biologics to treat a range of chronic and often life-threatening
diseases, with the potential to reduce costs and expand patient
access. For additional information, please visit
www.coherus.com.
CONTACT: Susanna Chau
Investor Relations
Coherus BioSciences, Inc.
schau@coherus.com
+1 (650) 649-3577
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Sep 2023 to Sep 2024